Acadia Healthcare (NASDAQ:ACHC) Given New $20.00 Price Target at Barclays

Key Points

• Barclays has reduced its price target for Acadia Healthcare from $28.00 to $20.00, maintaining an "equal weight" rating, which suggests a potential upside of 10.41% from its current price.
• Other analysts have also adjusted their price targets, with Mizuho cutting its target from $37.00 to $32.00 and KeyCorp lowering theirs from $65.00 to $55.00, while overall analyst consensus rates the stock as a "Moderate Buy" with an average target of $47.06.
• Acadia Healthcare recently reported a quarterly EPS of $0.83, exceeding estimates and reflecting a 9.2% year-over-year revenue growth to $869.23 million.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) had its price objective cut by research analysts at Barclays from $28.00 to $20.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an "equal weight" rating on the stock. Barclays's target price would suggest a potential upside of 10.41% from the stock's current price.

Other analysts also recently issued reports about the stock. Mizuho cut their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. KeyCorp decreased their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Stephens upgraded Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Guggenheim assumed coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They set a "buy" rating and a $36.00 price target for the company. Finally, Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $47.06.

Acadia Healthcare Trading Up 0.6%

NASDAQ:ACHC opened at $18.12 on Thursday. The stock has a 50-day simple moving average of $22.34 and a 200-day simple moving average of $28.23. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.35 and a current ratio of 1.35. Acadia Healthcare has a 1 year low of $17.13 and a 1 year high of $82.40. The stock has a market cap of $1.67 billion, a P/E ratio of 12.11, a P/E/G ratio of 4.15 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.36% and a net margin of 4.31%. The business had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same quarter in the previous year, the company earned $0.91 EPS. The company's quarterly revenue was up 9.2% on a year-over-year basis. As a group, analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd increased its position in Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after acquiring an additional 1,234 shares in the last quarter. Quadrant Capital Group LLC grew its position in shares of Acadia Healthcare by 287.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock worth $50,000 after buying an additional 933 shares during the period. UMB Bank n.a. boosted its stake in Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after acquiring an additional 755 shares during the last quarter. State of Wyoming acquired a new position in shares of Acadia Healthcare in the 4th quarter valued at $56,000. Finally, Covestor Ltd grew its stake in shares of Acadia Healthcare by 27.2% during the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock worth $58,000 after purchasing an additional 310 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.